Efficacy of low-dose intra-articular tranexamic acid in total knee replacement; A prospective triple-blinded randomized controlled trial

BMC Musculoskeletal Disorders

Volumn 14, Issue , 2013, Pages

  Sa Ngasoongsong, Paphon ^a   Wongsak, Siwadol ^a   Chanplakorn, Pongsthorn ^a   Woratanarat, Patarawan ^a   Wechmongkolgorn, Supaporn ^a   Wibulpolprasert, Bussanee ^a   Mulpruek, Pornchai ^a   Kawinwonggowit, Viroj ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Blood loss reduction; Blood transfusion reduction; Clamp drain technique; Intra articular tranexamic acid

Indexed keywords

HEMOGLOBIN; PLACEBO; SODIUM CHLORIDE; TRANEXAMIC ACID;

ADULT; AGED; ARTERY CLAMP; ARTICLE; BLOOD TRANSFUSION; BLOOD VOLUME; BODY MASS; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; ECHOGRAPHY; FEMALE; FOLLOW UP; HEMATOMA; HEMOGLOBIN BLOOD LEVEL; HUMAN; KNEE OSTEOARTHRITIS; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SURGICAL DRAINAGE; SURGICAL INFECTION; THROMBOEMBOLISM; TOTAL KNEE REPLACEMENT; TREATMENT OUTCOME; WOUND; WOUND CLOSURE;

AGED; ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD TRANSFUSION; CONSTRICTION; DRAINAGE; FEMALE; HUMANS; INJECTIONS, INTRA-ARTICULAR; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDIES; THAILAND; TIME FACTORS; TRANEXAMIC ACID; TREATMENT OUTCOME;

EID: 84889032616     PISSN: None     EISSN: 14712474     Source Type: Journal    
DOI: 10.1186/1471-2474-14-340     Document Type: Article

References (20)

1. Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention. Vamvakas EC, Blajchman MA, Blood 2009 113 3406 3417 10.1182/blood-2008-10-167643 19188662
2. Transfusion-transmitted infectious diseases. Allain JP, Stramer SL, Carneiro-Proietti AB, Martins ML, da Silva SN L, Ribeiro M, Proietti FA, Reesink HW, Biologicals 2009 37 71 77 10.1016/j.biologicals.2009.01.002 19231236
3. Tranexamic acid reduces allogeneic red cell transfusions in patients undergoing total knee arthroplasty: results of a meta-analysis of randomized controlled trials. Cid J, Lozano M, Transfusion 2005 45 1302 1307 10.1111/j.1537-2995.2005.00204.x 16078916 (Pubitemid 41647794)
4. Use of topical tranexamic acid or aminocaproic acid to prevent bleeding after major surgical procedures. Ipema HJ, Tanzi MG, The Annals of pharmacotherapy 2012 46 97 107 10.1345/aph.1Q383 22202494
5. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. Ker K, Edwards P, Perel P, Shakur H, Roberts I, BMJ 2012 344 3054 10.1136/bmj.e3054 22611164
6. Intra-articular injection of tranexamic acid reduces not only blood loss but also knee joint swelling after total knee arthroplasty. Ishida K, Tsumura N, Kitagawa A, Hamamura S, Fukuda K, Dogaki Y, Kubo S, Matsumoto T, Matsushita T, Chin T, et al. Int Orthop 2011 35 1639 1645 10.1007/s00264-010-1205-3 21253725
7. Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients. Maniar RN, Kumar G, Singhi T, Nayak RM, Maniar PR, Clin Orthop Relat Res 2012 470 2605 2612 10.1007/s11999-012-2310-y 22419350
8. Risk of deep venous thrombosis in drain clamping with tranexamic acid and carbazochrome sodium sulfonate hydrate in total knee arthroplasty. Onodera T, Majima T, Sawaguchi N, Kasahara Y, Ishigaki T, Minami A, J Arthroplasty 2012 27 105 108 10.1016/j.arth.2011.02.004 21435821
9. Postoperative blood loss reduction in computer-assisted surgery total knee replacement by low dose intra-articular tranexamic acid injection together with 2-hour clamp drain: a prospective triple-blinded randomized controlled trial. Sa-Ngasoongsong P, Channoom T, Kawinwonggowit V, Woratanarat P, Chanplakorn P, Wibulpolprasert B, Wongsak S, Udomsubpayakul U, Wechmongkolgorn S, Lekpittaya N, Orthop Rev (Pavia) 2011 3 12 22053253
10. Efficacy of intra-articular tranexamic acid in blood loss reduction following primary unilateral total knee arthroplasty. Roy SP, Tanki UF, Dutta A, Jain SK, Nagi ON, Knee Surg Sports Traumatol Arthrosc 2012
11. The comparative efficacies of intra-articular and IV tranexamic acid for reducing blood loss during total knee arthroplasty. Seo JG, Moon YW, Park SH, Kim SM, Ko KR, Knee Surg Sports Traumatol Arthrosc 2012
12. Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. Wong J, Abrishami A, El Beheiry H, Mahomed NN, Roderick Davey J, Gandhi R, Syed KA, Muhammad Ovais Hasan S, De Silva Y, Chung F, J Bone Joint Surg Am 2010 92 2503 2513 21048170
13. Intra-articular injection of tranexamic acid via a drain plus drain-clamping to reduce blood loss in cementless total knee arthroplasty. Mutsuzaki H, Ikeda K, J Orthop Surg Res 2012 7 32 10.1186/1749-799X-7-32 23020868
14. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Schulz KF, Altman DG, Moher D, BMJ 2010 340 332 10.1136/bmj.c332 20332509
15. New classification of physical status. American Society of Anesthesiologists, Inc, Anesthesiology 1963 24 111
16. Seeber P, Shander A, Basics of blood management Massachusetts, USA: Blackwell Publishing 1 2007
17. Rationale of the knee society clinical rating system. Insall JN, Dorr LD, Scott RD, Scott WN, Clin Orthop Relat Res 1989 13 14 PMID: 2805470 (Pubitemid 20204775)
18. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW, J Rheumatol 1988 15 1833 1840 3068365 (Pubitemid 19037656)
19. Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American society of anesthesiologists task force on perioperative blood transfusion and adjuvant therapies. American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies, Anesthesiology 2006 105 198 208 10.1097/00000542-200607000- 00030 16810012 (Pubitemid 44305209)
20. Determination of ideal body weight for drug dosage calculations. Robinson JD, Lupkiewicz SM, Palenik L, Lopez LM, Ariet M, Am J Hosp Pharm 1983 40 1016 1019 6869387 (Pubitemid 13095552)